ArticleBMJ open2024

Can SGLT-2 inhibitors improve cardiovascular outcomes and ensure safety for patients with type 2 diabetes and heart failure in Thailand? A real-world multicentre retrospective cohort study.

Tanawan Kongmalai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.